About
caVos Biotech uses comparative genomics and AI to systematically identify and validate evolutionarily conserved protein variants across species, developing novel mRNA therapeutics targeting diseases related to longevity such as fibrosis, tissue regeneration, and cancer.
Explore caVos Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.